advertisement
Abstract #13048 Published in IGR 7-3
Selective laser trabeculoplasty as a replacement for medical therapy in open-angle glaucoma
Francis BA; Ianchulev T; Schofield JK; Minckler DSAmerican Journal of Ophthalmology 2005; 140: 524-525
PURPOSE: To evaluate selective laser trabeculoplasty (SLT) as a replacement for medical therapy in controlled open-angle glaucoma. DESIGN: Prospective, non-randomized, interventional clinical trial. METHODS: SLT was performed inferiorly in 66 eyes of 66 patients with medically controlled primary open-angle glaucoma (OAG) or exfoliation glaucoma, and no history of glaucoma surgery. The primary outcome was number of medications at 6 and 12 months while maintaining a pre-determined target intraocular pressure (IOP). RESULTS: The mean of the differences in medications from baseline was 2.0 (95% confidence interval = 1.8-2.3) at 6 months, and 1.5 (1.27-1.73) at 12 months (P < .0001). The group mean of medications was 2.8 ± 1.1 at baseline, 0.7 ± 0.9 at 6 months, and 1.5 ± 0.9 at 12 months (P < .0001). Reduction in medications was attained in 64 of 66 eyes (97%) at 6 months, and 52 of 60 (87%) at 12 months. CONCLUSION: SLT enabled a reduction in medicine in controlled OAG over 12 months.
Dr. B.A. Francis, Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. bfrancis@usc.edu
Classification:
12.4 Laser trabeculoplasty and other laser treatment of the angle (Part of: 12 Surgical treatment)
11.1 General management, indication (Part of: 11 Medical treatment)
